Psycho-Oncology Services, CETTRO-Centro de Câncer de Brasília (Brasilia Cancer Center), Brasília, DF, Brazil.
Psychooncology. 2011 Oct;20(10):1130-3. doi: 10.1002/pon.1833. Epub 2010 Aug 25.
The objective of this study was to measure distress at three points during the course of chemotherapy: beginning, middle, and the last day of therapy in a private cancer center in Brazil.
One hundred patients were assessed at three points during chemotherapy using the Distress Thermometer (DT) and the Hospital Anxiety and Depression Scale (HADS). The data were analyzed with the support of SPSS 15.0 software.
At the beginning of chemotherapy, patients mean scores were distress (82%), anxiety (78%) and depression (55%). In the middle of treatment, the percentages of distress, anxiety and depression decreased to 36.4, 25 and 25.3%, respectively. On the last day, the levels were 18.2% for distress and 14.3% for both anxiety and depression.
Distress is highest in these patients at the beginning of chemotherapy, suggesting that evaluation of patients for psychosocial needs is important. Screening with a simple rapid instrument such as the DT is feasible and useful.
本研究旨在测量巴西一家私立癌症中心化疗过程中三个时间点的患者痛苦程度:化疗开始时、中期和最后一天。
100 名患者在化疗过程中的三个时间点使用痛苦温度计(DT)和医院焦虑抑郁量表(HADS)进行评估。使用 SPSS 15.0 软件对数据进行分析。
化疗开始时,患者的平均得分分别为痛苦(82%)、焦虑(78%)和抑郁(55%)。在治疗中期,痛苦、焦虑和抑郁的百分比分别下降至 36.4%、25%和 25.3%。最后一天,痛苦的水平为 18.2%,焦虑和抑郁的水平均为 14.3%。
这些患者在化疗开始时的痛苦程度最高,这表明评估患者的社会心理需求很重要。使用 DT 等简单快速的仪器进行筛查是可行且有用的。